Does Revlimid Weaken Your Immune System?
Revlimid (lenalidomide) is an oral medication commonly prescribed for the treatment of multiple myeloma and certain other blood disorders. While it has proven effective in controlling cancer symptoms and improving patient outcomes, many patients and caregivers express concerns about its potential impact on the immune system. Understanding how Revlimid affects immune function is crucial for patients navigating their treatment options. How Revlimid Works Revlimid belongs to a class of drugs known as immunomodulatory agents. It is believed to exert its therapeutic effects through multiple mechanisms, including enhancing the immune system's ability to target and eliminate cancer cells. Specifically, Revlimid can stimulate T-cell and natural killer (NK) cell activity, leading to improved anti-tumor immunity. Additionally, it inhibits the production of pro-inflammatory cytokines, which can contribute to cancer progression. The Immune System and Multiple Myeloma Multiple myeloma is charac...